CymitQuimica logo

CAS 223673-61-8

:

Mirabegron

Description:
Mirabegron is a pharmaceutical compound primarily used as a medication for the treatment of overactive bladder. It functions as a selective beta-3 adrenergic agonist, which means it stimulates beta-3 adrenergic receptors in the bladder, leading to relaxation of the detrusor muscle and increased bladder capacity. This mechanism helps alleviate symptoms such as urgency and frequency of urination. Mirabegron is characterized by its moderate lipophilicity, which influences its absorption and distribution in the body. The compound has a molecular formula that reflects its complex structure, including various functional groups that contribute to its pharmacological activity. It is typically administered orally and has a relatively long half-life, allowing for once-daily dosing. Common side effects may include hypertension, urinary tract infections, and headache. Overall, Mirabegron represents a significant advancement in the management of urinary conditions, providing an alternative to anticholinergic medications.
Formula:C21H24N4O2S
InChI:InChI=1/C21H24N4O2S/c22-21-25-18(14-28-21)12-20(27)24-17-8-6-15(7-9-17)10-11-23-13-19(26)16-4-2-1-3-5-16/h1-9,14,19,23,26H,10-13H2,(H2,22,25)(H,24,27)
InChI key:InChIKey=PBAPPPCECJKMCM-IBGZPJMESA-N
SMILES:N(C(CC1=CSC(N)=N1)=O)C2=CC=C(CCNC[C@H](O)C3=CC=CC=C3)C=C2
Synonyms:
  • (R)-Mirabegron
  • 2-(2-Amino-1,3-thiazol-4-yl)-N-[4-[2-[((2R)-2-hydroxy-2-phenylethyl)amino]ethyl]phenyl]acetamide
  • 2-(2-amino-1,3-thiazol-4-yl)-N-(4-{2-[(2-hydroxy-2-phenylethyl)amino]ethyl}phenyl)acetamide
  • 2-Amino-N-[4-[2-[[(2R)-2-hydroxy-2-phenylethyl]amino]ethyl]phenyl]-4-thiazoleacetamide
  • 4-Thiazoleacetamide, 2-amino-N-[4-[2-[[(2R)-2-hydroxy-2-phenylethyl]amino]ethyl]phenyl]-
  • Betanis
  • Betmiga
  • Mira veron
  • Myrbetriq
  • N-(4-(2-(2-hydroxy-2-phenylethylamino)ethyl)phenyl)-2-(2-aminothiazol-4-yl)acetamide
  • See more synonyms
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 15 products.